- Research works
- 21 ▼ 87% vs 2013–17
- Citations
- 192 9.3 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 27% world 28%
Not ranked overall: OncoPlex Diagnostics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at OncoPlex Diagnostics (United States)?
Ranked on the composite score, Jon Burrows and Todd Hembrough lead among researchers whose main affiliation is OncoPlex Diagnostics (United States).
- 1 Jon Burrows United States · #423,509 worldwide 71 citations · 16 works
- 2 Todd Hembrough United States · #542,100 worldwide 71 citations · 29 works
Which keywords describe research at OncoPlex Diagnostics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Chemotherapy, Cancer Genomics, Mutational Signatures, Mass Spectrometry, Proteomics, Quantitative Analysis and Tumor Microenvironment.
- Tumor Targeting
- Glycosylation
- Clinical Trials
- High-Throughput Analysis
- Protein Identification
- Precision Medicine
- Tumor Microenvironment
- Proteomics
- Mass Spectrometry
- Chemotherapy
- Targeted Therapy
- Cancer Genomics
- Mutational Signatures
- Quantitative Analysis
- Immunotherapy
- Phosphoproteomics
- Cancer
- Protein Microarrays
- Gene Expression
- Bacterial Therapy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 20 words, with their numbers
- Targeted Therapy4▲ 78×3 topics
- Chemotherapy3▲ 19×8 topics
- Cancer Genomics2▲ 206×1 topic
- Mass Spectrometry2▲ 52×3 topics
- Mutational Signatures2▲ 206×1 topic
- Proteomics2▲ 92×2 topics
- Quantitative Analysis2▲ 62×2 topics
- Tumor Microenvironment2▲ 23×4 topics
- Immunotherapy2▲ 12×4 topics
- Precision Medicine2▲ 26×4 topics
- Phosphoproteomics2▲ 295×1 topic
- Protein Identification2▲ 295×1 topic
- Cancer1▲ 4.8×8 topics
- High-Throughput Analysis1▲ 149×1 topic
- Protein Microarrays1▲ 345×1 topic
- Clinical Trials1▲ 9.0×3 topics
- Gene Expression1▲ 9.9×3 topics
- Glycosylation1▲ 24×2 topics
- Bacterial Therapy1▲ 111×1 topic
- Tumor Targeting1▲ 37×1 topic
Which research topics does OncoPlex Diagnostics (United States) publish most on?
By volume in 2022–2025: Biomedical and Engineering Education, Ethics in Clinical Research and Health and Medical Research Impacts.
- 1 Biomedical and Engineering Education Biomedical Engineering 0 works
- 2 Ethics in Clinical Research Public Health, Environmental and Occupational Health 0 works
- 3 Health and Medical Research Impacts Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has OncoPlex Diagnostics (United States)'s research output changed?
Output in 2018–2022 was 87% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rockville
- United States Nuclear Regulatory Commission
- Signal Processing (United States)
- Center for Devices and Radiological Health
- Agency for Healthcare Research and Quality
- Orthopaedic Center
- Biomedical Research Institute
- Westat (United States)
- Research Applications (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.